Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
Observational
OA: bronze
CC0
⤵ 5 in-corpus citations
AI-generated summary
This study investigated whether prolonged pituitary down-regulation with a GnRH agonist enhances live-birth rates in IVF treatments.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the effects of a prolonged duration of gonadotropin-releasing hormone agonist (GnRH-a) in pituitary down-regulation for controlled ovarian hyperstimulation (COH) on the live-birth rate in nonendometriotic women undergoing in vitro fertilization and embryo transfer (IVF-ET).
DESIGN: Retrospective cohort study.
SETTING: University-affiliated hospital.
PATIENT(S): Normogonadotropic women undergoing IVF.
INTERVENTION(S): Three hundred seventy-eight patients receiving a prolonged pituitary down-regulation with GnRH-a before ovarian stimulation and 422 patients receiving a GnRH-a long protocol.
MAIN OUTCOME MEASURE(S): Live-birth rate per fresh ET.
RESULT(S): In comparison with the long protocol, the prolonged down-regulation protocol required a higher total dose of gonadotropins. A lower serum luteinizing hormone (LH) level on the starting day of gonadotropin and the day of human chorionic gonadotropin (hCG) and a fewer number of oocytes and embryos were observed in the prolonged down-regulation protocol. However, the duration of stimulation and number of high-quality embryos were comparable between the two groups. A statistically significantly higher implantation rate (50.27% vs. 39.69%), clinical pregnancy rate (64.02% vs. 56.87%) and live-birth rate per fresh transfer cycle (55.56% vs. 45.73%) were observed in the prolonged protocol.
CONCLUSION(S): Prolonged down-regulation in a GnRH-a protocol might increase the live-birth rates in normogonadotropic women.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (44)
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex
- Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study via openalex
- Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex
- Ovarian stimulation for in vitro fertilization in patients with endometriosis via openalex
- Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression via openalex
- doi:10.1016/s0015-0282(98)00123-x via openalex
- doi:10.1016/j.ejogrb.2011.06.030 via openalex
- doi:10.1186/1477-7827-1-125 via openalex
- doi:10.1198/016214508000000733 via openalex
- doi:10.1093/humupd/dmt030 via openalex
- doi:10.1159/000292997 via openalex
- doi:10.1016/j.fertnstert.2007.01.013 via openalex
- doi:10.1093/humrep/del173 via openalex
- doi:10.1093/humrep/del215 via openalex
- doi:10.1093/humrep/16.3.492 via openalex
- doi:10.1186/1477-7827-8-30 via openalex
- doi:10.1093/humrep/17.8.2016 via openalex
- doi:10.1093/humrep/15.5.1003 via openalex
- doi:10.1186/1477-7827-10-26 via openalex
- doi:10.1016/s0015-0282(16)60435-1 via openalex
- doi:10.1093/molehr/5.3.234 via openalex
- doi:10.1093/humrep/deh183 via openalex
- doi:10.1093/oxfordjournals.humrep.a136126 via openalex
- doi:10.1016/j.fertnstert.2006.05.064 via openalex
- doi:10.4103/0974-1208.97785 via openalex
- doi:10.1093/humrep/deh235 via openalex
- doi:10.1016/s1472-6483(10)60781-x via openalex
- doi:10.3109/09513599209015549 via openalex
- doi:10.1016/s0301-2115(98)00125-0 via openalex
- doi:10.1093/humrep/10.suppl_2.60 via openalex
- doi:10.1016/0140-6736(91)90427-q via openalex
- doi:10.1016/j.fertnstert.2007.07.1316 via openalex
- doi:10.1159/000214844 via openalex
- doi:10.1007/s10815-006-9051-3 via openalex
- doi:10.1016/j.fertnstert.2008.11.027 via openalex
- doi:10.1186/1477-7827-6-37 via openalex
- doi:10.1016/s1472-6483(10)61729-4 via openalex
- doi:10.1016/s1472-6483(10)60426-9 via openalex
- doi:10.1007/bf01203956 via openalex
- doi:10.1093/humrep/13.7.1788 via openalex
Cited by (5)
- Turning Challenges into Success: Successful Pregnancy in Advanced Maternal Age with Adenomyosis Using Prolonged GnRH Agonist Protocol: A Case Report 2026
- Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III-IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization 2020
- Peer Review #1 of "Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study (v0.1)" 2019
- Efficacy and Safety of In Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Among Patients with Endometriosis After a Shortened Protocol of Long-Term Pituitary Downregulation 2019
- GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation 2018
Source provenance
- openalex
- last seen: 2026-05-11T06:01:13.017405+00:00
- pubmed
- last seen: 2026-10-08T21:13:34.636433+00:00
License: CC0
· commercial use OK